selected publications
-
academic article
- DUSP9-mediated reduction of pERK1/2 supports cancer stem cell-like traits and promotes triple negative breast cancer.. American journal of cancer research. 10:3487-3506. 2020
- Metabolic profiling of follistatin overexpression: a novel therapeutic strategy for metabolic diseases.. Diabetes, metabolic syndrome and obesity : targets and therapy. 65-84. 2018
- Modulation of transforming growth factor-β/follistatin signaling and white adipose browning: therapeutic implications for obesity related disorders.. Hormone molecular biology and clinical investigation. 31. 2017
- Follistatin Targets Distinct Pathways To Promote Brown Adipocyte Characteristics in Brown and White Adipose Tissues.. Endocrinology. 158:1217-1230. 2017
- Follistatin promotes adipocyte differentiation, browning, and energy metabolism.. Journal of lipid research. 55:375-84. 2014
- Inhibition of in vitro and in vivo brown fat differentiation program by myostatin.. Obesity (Silver Spring, Md.). 21:1180-8. 2013
- Down-regulation of vitamin D receptor in mammospheres: implications for vitamin D resistance in breast cancer and potential for combination therapy.. PloS one. 8:-. 2013